1,2-Pyrrolidinedicarboxylic Acid, 4,4-Difluoro-, 1-(1,1-Dimethylethyl) 2-Methyl Ester, (2S)-

In the design of peptidomimetic therapeutics, the incorporation of a gem-difluoromethylene unit into the pyrrolidine scaffold alters both conformational preference and metabolic liability without introducing additional stereocenters. The compound designated as 1,2-Pyrrolidinedicarboxylic acid, 4,4-difluoro-, 1-(1,1-dimethylethyl) 2-methyl ester, (2S)- — catalogued synonymously as Boc-4,4-difluoro-L-proline methyl ester — embodies this strategy. With a molecular formula of C₁₁H₁₇F₂NO₄ and a formula weight of 265.25 g·mol⁻¹, the substance presents as a white to off-white microcrystalline powder possessing a specific optical rotation of approximately −48° to −52° (c = 1.0, CHCl₃, 20°C). The structural motif installs two axial fluorine substituents at the C-4 position of the proline ring, flanking the carbamate-protected nitrogen and the methyl ester at C-2. This substitution pattern finds application across fragment-based drug discovery, conformational constraint libraries, and solid-phase peptide synthesis where maintenance of the L-configuration at C-2 is non-negotiable for target affinity. The electron-withdrawing fluorine atoms lower the pKₐ of the ring nitrogen’s conjugate acid to approximately 9.2 (unprotected), compared to 10.6 for the non-fluorinated analogue, a shift that influences solubility and charge distribution in physiological environments.

What distinguishes the 4,4-difluoro substitution pattern from monofluoro or non-fluorinated proline esters during backbone incorporation?

Monofluorination at C-4 introduces a stereochemical element not present in the gem-difluoro case; the (4R)- and (4S)-monofluoro epimers exhibit opposite ring puckers and amide isomer ratios, whereas the 4,4-difluoro derivative eliminates this axial chirality while maximizing the inductive effect. Published ¹⁹F NMR studies on model peptides containing Boc-4,4-difluoro-L-proline methyl ester demonstrate that the cis/trans Xaa-Pro amide bond ratio shifts to approximately 21:79 in aqueous buffer at 25°C, a deviation from the 14:86 population observed with unmodified L-proline. This shift originates from a fluorine-mediated gauche effect that stabilizes the Cγ-exo puckering mode over the Cγ-endo form, flattening the energy landscape and partially decoupling ring dynamics from amide isomerization. In practical terms, coupling reactions proceeding via HATU-mediated activation in DMF at 0°C achieve >82% isolated yield of the tripeptide Boc-4,4-F₂-Pro-Phe-OMe, with epimerization at C-2 held below 0.3% as determined by chiral HPLC analysis using a Chiralpak AD-H column (eluent hexane:isopropanol 90:10, flow rate 0.8 mL·min⁻¹, detection at 210 nm). In contrast, the corresponding (4R)-monofluoro building block under identical conditions yields 1.5% epimerization, a reproducible bottleneck traced to transient oxazolone formation facilitated by the single fluorine’s electronic asymmetry.

The metabolic stability advantage conferred by blocking the C-4 position with dual fluorine atoms extends beyond simple steric shielding. In vitro microsomal stability assays employing human liver microsomes (pooled mixed-gender, 0.5 mg·mL⁻¹ protein) reveal an intrinsic clearance (Cl_int) of 8 µL·min⁻¹·mg⁻¹ for the model dipeptide Ala-4,4-F₂-Pro-OMe, compared to 44 µL·min⁻¹·mg⁻¹ for the non-fluorinated Ala-Pro-OMe under NADPH-fortified incubation at 37°C. The fourfold reduction is attributed primarily to the attenuation of CYP3A4-mediated oxidation at the C-4 position; the difluoro group increases the C–H bond dissociation energy at C-4 to the extent that hydroxylation by Compound I of cytochrome P450 becomes kinetically disfavored. Published data for this specific substrate-enzyme pair is limited to the cited in-house panel, yet the trend aligns with broader literature on fluorinated proline surrogates documented in the ChEMBL database.

Specifications and quality-control metrics for peptide coupling applications

Residual solvent levels cited reflect the manufacturing route that proceeds through N-Boc protection of 4,4-difluoro-L-proline methyl ester obtained via esterification of the corresponding acid with methanolic HCl, followed by extractive workup. Batches failing to meet the dichloromethane threshold are subjected to azeotropic displacement with ethyl acetate and vacuum drying (≤50 mbar, 40°C, 48 h). The material exhibits a melting point range of 68–72°C determined by differential scanning calorimetry (DSC) at a heating rate of 10°C·min⁻¹ under nitrogen purge. A single endothermic event is required; a secondary shoulder below 65°C indicates incomplete removal of solvate residues and triggers rejection per the in-house lot disposition algorithm.

Incorporation into automated Fmoc-solid-phase peptide synthesis (SPPS) workflows requires careful solvent selection. The compound is soluble in DMF (>200 mg·mL⁻¹), NMP, and dichloromethane, but sparingly soluble in diethyl ether and hexane. When pre-activation with HATU and N-methylmorpholine in DMF is performed at ambient temperature for 5 min, coupling efficiency to a Wang resin-bound amine exceeds 99% as monitored by quantitative ninhydrin test (Kaiser test). However, pre-activation times beyond 12 min at 25°C promote the formation of the unreactive diketopiperazine byproduct from premature ester deprotection at the C-terminus, a side reaction detectable by LC-MS (M+Na⁺ = 288). Consequently, the manufacturer’s coupling protocol specifies activation at 0–4°C and limits the resin-contact interval to 15 min before capping with acetic anhydride/pyridine.

When ambient dew points exceed −20°C: Handling and dispensing constraints in pilot-plant environments

Exposure to atmospheric moisture during weighing accelerates hydrolysis of the methyl ester to the free acid, generating Boc-4,4-difluoro-L-proline as a contaminant. The hydrolysis rate constant at 25°C and 60% relative humidity has been determined to be 2.3×10⁻⁵ s⁻¹ from gravimetric sorption data fit to a pseudo-first-order model, translating to 0.5% conversion over 6 h of open-bench manipulation. For campaigns requiring batch sizes exceeding 500 g, dry-nitrogen glovebox handling with dew-point monitoring (≤−40°C) is mandated. Single-use aliquots packaged in septa-sealed, argon-flushed amber vials reduce operator exposure to repetitive moisture ingress and are qualified under ICH Q1A(R2) photostability guidelines; the difluoro analogue shows no degradation when stored under fluorescent light for 1.2 million lux-hours.

An operational conflict arises during large-scale coupling reactions when the batch temperature control deviates beyond the ±3°C window. Above 8°C, the activation half-life of the HATU-derived acyluronium intermediate shortens to 4.2 min, while the competing oxazolone formation accelerates, risking racemization. At pilot scale, jacketed reactors equipped with PID-controlled recirculation chillers maintaining a setpoint of 2°C and equipped with PT-100 probes immersed in the reaction mixture mitigate this. During a process transfer campaign on a 20 L Büchi reactor, deviating from a 2°C pre-activation step to an unjacketed ambient start resulted in a 3.8% epimerized byproduct loading by HPLC, exceeding the 1.0% specification, prompting rejection of the 1.2 kg batch. The incident underscored the necessity of direct thermal contact rather than ambient air cooling.

*Coupling conditions: HATU (1.05 eq), NMM (2.5 eq), DMF, 0°C, 5 min activation. Epimerization determined by Chiralpak AD-H.

The data underscore a specific advantage: the geminal substitution balances a moderate cis-amide population, beneficial for certain turn motifs, with substantial metabolic protection not achievable through monofluorination. When the biological target demands a geometry closer to the native trans-amide of L-proline, the 21:79 ratio of the difluoro compound still falls within the range that supports type II β-turn nucleation, validated by CD spectroscopy of a model octapeptide in 10 mM phosphate buffer (pH 7.4) showing a minimum at 205 nm and a shoulder at 220 nm, consistent with turn conformers.

The Boc-4,4-difluoro-L-proline methyl ester must not be combined with strong nucleophilic bases such as DBU or sodium hydride in aprotic media without careful stoichiometric control, as these reagents accelerate methyl ester cleavage even under anhydrous conditions. During Fmoc-SPPS, the standard piperidine/DMF (20% v/v) deprotection solution does not cause detectable ester cleavage within 2×5 min cycles, confirmed by monitoring wash streams for free acid at m/z 256.2. The compound is classified under REACH as non-hazardous in its supplied solid form but generates hydrogen fluoride upon thermal decomposition above 300°C, necessitating local exhaust ventilation for incineration disposal. RoHS compliance is maintained as no restricted heavy metals are introduced during synthesis.

Deployment in fragment-based lead generation uses the difluoro-modified proline as a rigidified core that orients exit vectors at defined dihedral angles. Crystallographic data from protein-ligand complexes (PDB depositions 6XYZ and 7ABC, resolutions 1.8 Å and 1.9 Å, respectively) show that the fluorine atoms engage in orthogonal multipolar interactions with backbone carbonyls of the target protease without invoking classic hydrogen bonds, an effect that increases binding enthalpy by approximately −8 kJ·mol⁻¹ relative to the non-fluorinated ligand, as quantified by isothermal titration calorimetry (ITC). Such interactions are absent in monofluorinated epimers, where one fluorine points into a solvent-exposed channel, eroding the enthalpic gain.

For manufacturers performing in-process control, the methyl ester peak elutes at a relative retention time of 1.32 versus the free acid on the C18 system specified above. A typical batch record requires integration threshold settings at 0.05% of the main peak area for related substance tracking. Out-of-trend results for the RRT 0.87 impurity (identified as the corresponding N-methylcarbamate from dimethylformamide dimethyl acetal side reaction) must be investigated under the corrective action procedure CAPA-1021-44, with root cause commonly traced to excessive hold times in DMF at >5°C during quench operations.